Logo image of DSS

DSS INC (DSS) Stock Fundamental Analysis

NYSEARCA:DSS - NYSE Arca - US26253C2017 - Common Stock - Currency: USD

0.91  +0.03 (+3.4%)

Fundamental Rating

1

Taking everything into account, DSS scores 1 out of 10 in our fundamental rating. DSS was compared to 83 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of DSS have multiple concerns. DSS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DSS had negative earnings in the past year.
DSS had a negative operating cash flow in the past year.
DSS had negative earnings in 4 of the past 5 years.
In the past 5 years DSS always reported negative operating cash flow.
DSS Yearly Net Income VS EBIT VS OCF VS FCFDSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M

1.2 Ratios

DSS's Return On Assets of -31.08% is on the low side compared to the rest of the industry. DSS is outperformed by 89.29% of its industry peers.
DSS's Return On Equity of -85.08% is on the low side compared to the rest of the industry. DSS is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
ROA -31.08%
ROE -85.08%
ROIC N/A
ROA(3y)-29.46%
ROA(5y)-20.13%
ROE(3y)-64.74%
ROE(5y)-43.02%
ROIC(3y)N/A
ROIC(5y)N/A
DSS Yearly ROA, ROE, ROICDSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DSS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DSS Yearly Profit, Operating, Gross MarginsDSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

2

2. Health

2.1 Basic Checks

DSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
DSS has more shares outstanding than it did 1 year ago.
DSS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DSS is higher compared to a year ago.
DSS Yearly Shares OutstandingDSS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
DSS Yearly Total Debt VS Total AssetsDSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

DSS has an Altman-Z score of -2.81. This is a bad value and indicates that DSS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.81, DSS is not doing good in the industry: 89.29% of the companies in the same industry are doing better.
DSS has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
DSS has a better Debt to Equity ratio (0.14) than 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z -2.81
ROIC/WACCN/A
WACC7.69%
DSS Yearly LT Debt VS Equity VS FCFDSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.16 indicates that DSS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.16, DSS is doing worse than 69.05% of the companies in the same industry.
DSS has a Quick Ratio of 1.11. This is a normal value and indicates that DSS is financially healthy and should not expect problems in meeting its short term obligations.
DSS has a Quick ratio of 1.11. This is in the lower half of the industry: DSS underperforms 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.11
DSS Yearly Current Assets VS Current LiabilitesDSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

2

3. Growth

3.1 Past

DSS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.89%, which is quite impressive.
DSS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -40.24%.
Measured over the past years, DSS shows a quite strong growth in Revenue. The Revenue has been growing by 10.32% on average per year.
EPS 1Y (TTM)42.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.58%
Revenue 1Y (TTM)-40.24%
Revenue growth 3Y25.34%
Revenue growth 5Y10.32%
Sales Q2Q%33.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DSS Yearly Revenue VS EstimatesDSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
DSS Yearly EPS VS EstimatesDSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DSS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 90.10, which means the current valuation is very expensive for DSS.
DSS's Price/Forward Earnings is on the same level as the industry average.
DSS is valuated expensively when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 90.1
DSS Price Earnings VS Forward Price EarningsDSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DSS Per share dataDSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

DSS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DSS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DSS INC

NYSEARCA:DSS (3/7/2025, 8:20:25 PM)

0.91

+0.03 (+3.4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)03-25 2025-03-25/bmo
Inst Owners1.72%
Inst Owner Change-25.8%
Ins Owners30.96%
Ins Owner Change0.63%
Market Cap6.43M
Analysts80
Price TargetN/A
Short Float %1.53%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 90.1
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B 0.12
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)-6.31
EYN/A
EPS(NY)0.01
Fwd EY1.11%
FCF(TTM)-1.06
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS2.93
BVpS7.37
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.08%
ROE -85.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.46%
ROA(5y)-20.13%
ROE(3y)-64.74%
ROE(5y)-43.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.11%
Cap/Sales 0.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.11
Altman-Z -2.81
F-Score3
WACC7.69%
ROIC/WACCN/A
Cap/Depr(3y)262.29%
Cap/Depr(5y)186.27%
Cap/Sales(3y)56.13%
Cap/Sales(5y)35.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.58%
EPS Next Y100.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.24%
Revenue growth 3Y25.34%
Revenue growth 5Y10.32%
Sales Q2Q%33.88%
Revenue Next Year-0.25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y84.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.96%
OCF growth 3YN/A
OCF growth 5YN/A